Gsk Press Release Q1 2025
Gsk Press Release Q1 2025. Important step towards gsk’s global target of 100% purchased renewable electricity across all sites by end 2025. Q1 fiscal 2025 financial results total revenue for fy25 q1 was $40 million, compared to $61 million for the same period in the prior year, representing a decrease of.
Dosing of first patients under the phase 3 trial is planned for the first half of 2024. Gsk will share specific details closer to implementation.